All Inventions from Dr. Gary Nabel

  • Antiviral Compounds with Broad Neutralization Capabilities
    •
       Ref: E-013-2006-1 | Updated: Feb 17, 2021 | NIAID
  • Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine
    •
       Ref: E-293-2011-0 | Updated: Aug 3, 2020 | NIAID
  • Broadly Neutralizing Antibodies Against HIV-1 Directed to the CD4 Binding Site of HIV Envelope Protein
    •
       Ref: E-300-2009-0 | Updated: Jun 22, 2018 | NIAID
  • Resurfaced Stabilized Core 3 (RSC3) Protein, Derived Proteins, and DNA Encoding These Proteins: RSC3, RSC3...
    •
       Ref: E-236-2016-0 | Updated: Jun 7, 2018 | NIAID
  • Novel Epstein-Barr Virus Vaccines
    •
       Ref: E-531-2013-0 | Updated: Dec 17, 2015 | NIAID
  • Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most...
    •
       Ref: E-253-2011-0 | Updated: Jun 18, 2014 | NIAID
  • Bispecific Antibodies to Target Latent HIV-1 Infection
    •
       Ref: E-071-2012-0 | Updated: Jan 6, 2014 | NIAID
  • Influenza Vaccines, Therapeutics, and Monoclonal Antibodies
    •
       Ref: E-116-2006-0 | Updated: Oct 21, 2009 | NIAID
  • Enhanced Immune Response Against Influenza Virus by Priming with a DNA-based Vaccine
    •
       Ref: E-341-2008-0 | Updated: Jun 8, 2009 | NIAID
  • Assay for Identification of Influenza-Neutralizing Antibodies
    •
       Ref: E-323-2007-0 | Updated: Apr 1, 2008 | NIAID
  • Chimeric SHIV Gag Proteins Optimize T-Cell Response Against HIV Gag
    •
       Ref: E-241-2001-1 | Updated: Dec 1, 2007 | NIAID
  • Increased Protein Expression Vector for Vaccine Applications
    •
       Ref: E-241-2001-0 | Updated: Jun 1, 2007 | NIAID
  • Enhanced, Targeted Delivery for DNA Vaccines
    •
       Ref: E-043-2006-0 | Updated: May 1, 2007 | NIAID
  • Candidate DNA HIV Vaccine
    •
       Ref: E-267-2004-0 | Updated: Apr 1, 2005 | NIAID
  • Inhibition of HIV Replication in Resting CD4+ Lymphocytes by Murr1
    •
       Ref: E-042-2004-0 | Updated: Jun 1, 2004 | NIAID
  • Mechanisms for Improving the Breadth of the Immune Response to Diverse Strains and Clades of HIV
    •
       Ref: E-335-2003-0 | Updated: Jun 1, 2004 | NIAID
  • Assays for Assembly of Ebola Virus Pseudoparticles Relevant to Antiviral Therapy and Vaccines
    •
       Ref: E-090-2002-0 | Updated: Dec 1, 2002 | NIAID
  • Immunization for Ebola Virus Infection
    •
       Ref: E-246-2001-0 | Updated: May 1, 2002 | NIAID

    Displaying 1 - 18 of 18

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057